Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Penumbra Inc (PEN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/02/2023 |
8-K
| Quarterly results |
| 02/23/2023 |
8-K
| Quarterly results |
| 11/03/2022 |
8-K
| Quarterly results |
| 08/04/2022 |
8-K
| Quarterly results |
| 05/03/2022 |
8-K
| Quarterly results |
| 02/22/2022 |
8-K
| Quarterly results |
| 11/03/2021 |
8-K
| Quarterly results |
| 05/04/2021 |
8-K
| Quarterly results |
| 02/23/2021 |
8-K
| Quarterly results |
| 10/28/2020 |
8-K
| Quarterly results |
| 08/03/2020 |
8-K
| Quarterly results |
| 05/07/2020 |
8-K
| Quarterly results |
| 02/25/2020 |
8-K
| Quarterly results |
| 11/07/2019 |
8-K
| Quarterly results |
| 08/06/2019 |
8-K
| Quarterly results |
| 05/07/2019 |
8-K
| Quarterly results |
| 02/26/2019 |
8-K
| Quarterly results |
| 11/05/2018 |
8-K
| Quarterly results |
| 05/08/2018 |
8-K
| Quarterly results|
Docs:
|
"Penumbra, Inc. Reports First Quarter 2018 Financial Results ALAMEDA, Calif., May 8, 2018 - Penumbra, Inc. , a global healthcare company focused on innovative therapies, today reported financial results for the first quarter ended March 31, 2018. • Revenue of $102.7 million in the first quarter of 2018, an increase of 40.3%, or 36.2% in constant currency 1 , over the first quarter of 2017. First Quarter 2018 Financial Results Total revenue grew to $102.7 million for the first quarter of 2018 compared to $73.2 million for the first quarter of 2017, an increase of 40.3%, or 36.2% on a constant currency basis. The United States represented 64% of total revenue and international represented 36% of total revenue for the first quarter of 2018. Revenue from sales of neuro products grew to $71.4 mi..." |
|
| 02/27/2018 |
8-K
| Quarterly results |
| 11/07/2017 |
8-K
| Quarterly results|
Docs:
|
"Penumbra, Inc. Reports Third Quarter 2017 Financial Results ALAMEDA, Calif., November 7, 2017 - Penumbra, Inc. , a global healthcare company focused on interventional therapies, today reported financial results for the third quarter ended September 30, 2017. • Revenue of $83.9 million in the third quarter of 2017, an increase of 24.9%, or 24.1% in constant currency 1 , over the third quarter of 2016. Third Quarter 2017 Financial Results Total revenue grew to $83.9 million for the third quarter of 2017 compared to $67.2 million for the third quarter of 2016, an increase of 24.9%, or 24.1% on a constant currency basis. The United States represented 66% of total revenue and international represented 34% of total revenue for the third quarter of 2017. Revenue from sales of neuro products grew ..." |
|
| 08/08/2017 |
8-K
| Quarterly results|
Docs:
|
"Penumbra, Inc. Reports Second Quarter 2017 Financial Results ALAMEDA, Calif., August 8, 2017 - Penumbra, Inc. , a global healthcare company focused on interventional therapies, today reported financial results for the second quarter ended June 30, 2017. • Revenue of $80.6 million in the second quarter of 2017, an increase of 23.8%, or 24.6% in constant currency 1 , over the second quarter of 2016. Second Quarter 2017 Financial Results Total revenue grew to $80.6 million for the second quarter of 2017 compared to $65.1 million for the second quarter of 2016, an increase of 23.8%, or 24.6% on a constant currency basis. The U.S. represented 66.3% of total revenue and international represented 33.7% of total revenue for the second quarter of 2017. Revenue from sales of neuro products grew to $..." |
|
| 05/09/2017 |
8-K
| Form 8-K - Current report |
| 02/28/2017 |
8-K
| Form 8-K - Current report |
| 11/03/2016 |
8-K
| Form 8-K - Current report |
| 08/09/2016 |
8-K
| Quarterly results |
| 05/09/2016 |
8-K
| Form 8-K - Current report |
| 03/08/2016 |
8-K
| Form 8-K - Current report |
| 11/12/2015 |
8-K
| Quarterly results|
Docs:
|
"Penumbra, Inc. Reports Third Quarter 2015 Financial Results ALAMEDA, Calif., November 12, 2015 - Penumbra, Inc. , a global interventional therapies company, today reported financial results for the third quarter ended September 30, 2015. • Revenue of $50.4 million, an increase of 55.3%, or 61.0% in constant currency 1 , over the third quarter of 2014. • The Company closed its IPO on September 23, 2015, in which it sold 4.6 million shares of common stock at an offering price of $30.00 per share and raised approximately $124.8 million in net proceeds. Third Quarter 2015 Financial Results Total revenue grew to $50.4 million for the third quarter of 2015 compared to $32.5 million for the third quarter of 2014, an increase of 55.3%, or 61.0% on a constant currency basis. The U.S. represented 70..." |
|
|
|